Published in Epidemiol Infect on June 01, 1991
Effect of testing method on apparent activities of antiviral disinfectants and antiseptics. Antimicrob Agents Chemother (1995) 0.92
Methodological approaches to disinfection of human hepatitis B virus. J Clin Microbiol (1993) 0.81
Does limited virucidal activity of biocides include duck hepatitis B virucidal action? BMC Infect Dis (2012) 0.78
Inhibition of duck hepatitis B virus replication by mimic peptides in vitro. Exp Ther Med (2015) 0.75
Is hepatitis B-virucidal validation of biocides possible with the use of surrogates? World J Gastroenterol (2014) 0.75
Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate. Cell (1982) 16.71
Asymmetric replication of duck hepatitis B virus DNA in liver cells: Free minus-strand DNA. Proc Natl Acad Sci U S A (1982) 4.69
Transcripts and the putative RNA pregenome of duck hepatitis B virus: implications for reverse transcription. Cell (1985) 4.41
Susceptibility of hepatitis B virus to disinfectants or heat. J Clin Microbiol (1984) 1.70
Inactivation of hepatitis B virus by intermediate-to-high-level disinfectant chemicals. J Clin Microbiol (1983) 1.66
Hepadna viruses: hepatitis B and related viruses. Curr Top Microbiol Immunol (1983) 1.47
Epidemic hepatitis in a clinical laboratory. Possible association with computer card handling. JAMA (1974) 1.36
Duck hepatitis B virus and liver diseases. Gastroenterology (1983) 1.32
Viral hepatitis B infection risk in flexible fiberoptic endoscopy. Gastrointest Endosc (1978) 1.03
Differentiation of schistosomes by species, strain, and sex by using cloned DNA markers. Proc Natl Acad Sci U S A (1984) 0.91
Use of animal models to study hepatitis B virus. Prog Med Virol (1988) 0.90
Natural duck hepatitis B virus infection in Australia. Aust J Exp Biol Med Sci (1986) 0.90
Experimental duck hepatitis B virus infection: pathology and evolution of hepatic and extrahepatic infection. Hepatology (1988) 0.89
Chemical inactivation of hepatitis B virus: the effect of disinfectants on virus-associated DNA polymerase activity, morphology and infectivity. J Virol Methods (1983) 0.85
Serum hepatitis at a home for the aged. Scand J Infect Dis (1972) 0.79
Parvovirus-like particles in human sera. Lancet (1975) 7.11
Post-transfusion hepatitis revisited. Med J Aust (1995) 2.46
Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A. Infect Immun (1994) 2.25
Studies of Australia-SH antigen in sporadic viral hepatitis in London. Br Med J (1970) 2.13
Structural and biochemical characterization of the type III secretion chaperones CesT and SigE. Nat Struct Biol (2001) 2.04
Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis. J Pediatr (1976) 1.98
Application of a screening test for antibody the hepatitis B core antigen. J Clin Pathol (1977) 1.85
Evolution of poliovirus since introduction of attenuated vaccine. Br Med J (1977) 1.82
Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond) (2006) 1.76
Chemical andropause and amyloid-beta peptide. JAMA (2001) 1.75
Needlestick injury in medical students. Med J Aust (1994) 1.68
Isolation and characterization of toluene-sensitive mutants from the toluene-resistant bacterium Pseudomonas putida GM73. J Bacteriol (1998) 1.68
Post-transfusion hepatitis in Australia. Report of the Australian Red Cross study. Lancet (1982) 1.66
Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A. Proc Natl Acad Sci U S A (1994) 1.43
Tuberculosis: medical students at risk. Med J Aust (1994) 1.43
Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer (2005) 1.42
Reduction of group B streptococcal maternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test. Am J Obstet Gynecol (1987) 1.38
Binding hot spots in the TEM1-BLIP interface in light of its modular architecture. J Mol Biol (2006) 1.34
Epidemiology of serum hepatitis. Br Med Bull (1972) 1.33
Genetic marker studies of poliovirus. I. Natural variation. J Hyg (Lond) (1967) 1.30
Detection of persistent vegetative bacteria and amplified viral nucleic acid from in-use testing of gastrointestinal endoscopes. J Hosp Infect (1998) 1.28
Structural basis of non-specific lipid binding in maize lipid-transfer protein complexes revealed by high-resolution X-ray crystallography. J Mol Biol (2001) 1.24
Hepatitis in dialysis units in the United Kingdom. Br Med J (1972) 1.23
A functional study of plasma-membrane calcium-pump isoform 2 mutants causing digenic deafness. Proc Natl Acad Sci U S A (2007) 1.22
Australia antigen and heaptitis: a review. J Clin Pathol (1971) 1.16
The cell attachment proteins of type 1 and type 3 reovirus are differentially susceptible to trypsin and chymotrypsin. Virology (1989) 1.16
Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours. Vet Comp Oncol (2011) 1.15
Is biofilm accumulation on endoscope tubing a contributor to the failure of cleaning and decontamination? J Hosp Infect (2004) 1.15
Duck hepatitis B virus DNA in liver, spleen, and pancreas: analysis by in situ and Southern blot hybridization. Virology (1987) 1.14
Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat (1997) 1.14
Binding of the arginine repressor of Escherichia coli K12 to its operator sites. J Mol Biol (1992) 1.13
Multicopy single-stranded DNA of Escherichia coli enhances mutation and recombination frequencies by titrating MutS protein. Mol Microbiol (1996) 1.08
Deletion of a short, untranslated region adjacent to the polypurine tract in Moloney murine leukemia virus leads to formation of aberrant 5' plus-strand DNA ends in vivo. J Virol (2000) 1.07
Virus-liver cell interactions in duck hepatitis B virus infection. A study of virus dissemination within the liver. Gastroenterology (1988) 1.06
User's guide to some new tests for hepatitis-B antigen. Lancet (1974) 1.05
Asiatic acid derivatives protect cultured cortical neurons from glutamate-induced excitotoxicity. Res Commun Mol Pathol Pharmacol (2001) 1.03
Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet (1970) 1.03
Sexually inappropriate behaviour in demented elderly people. Postgrad Med J (2005) 1.02
Reduction of pain on injection of propofol: combination of pretreatment of remifentanil and premixture of lidocaine with propofol. Eur J Anaesthesiol (2007) 1.00
Multicopy single-stranded DNAs with mismatched base pairs are mutagenic in Escherichia coli. Mol Microbiol (1994) 0.99
A critical review of admission and discharge medications in an elderly Australian population. Drugs Aging (1993) 0.98
Genetic independence between the HL--A system and deficits in the first and sixth components of complement. Tissue Antigens (1976) 0.98
Impact of rubella vaccination in Australia. Lancet (1984) 0.98
Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. Brain Res Bull (2003) 0.97
A novel retron that produces RNA-less msDNA in Escherichia coli using reverse transcriptase. Plasmid (1997) 0.97
Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer Prostatic Dis (2008) 0.97
Latex test for AU antigen. Lancet (1972) 0.97
Guillain-Barré syndrome associated with Campylobacter infection. Aust N Z J Med (1984) 0.95
Seroprevalence of markers for hepatitis B, C and G in male and female prisoners--NSW, 1996. Aust N Z J Public Health (1999) 0.95
Differential mRNA expression of prostaglandin receptor subtypes in macrophage activation. Prostaglandins Leukot Essent Fatty Acids (2002) 0.94
Australia antigen and the human fetus. Am J Dis Child (1972) 0.93
Human papillomavirus: the untreated male reservoir. J Urol (1988) 0.92
Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. Gynecol Oncol (1997) 0.91
An enzyme-linked immunosorbent-assay test for hepatitis B surface antigen. J Clin Pathol (1977) 0.91
Natural duck hepatitis B virus infection in Australia. Aust J Exp Biol Med Sci (1986) 0.90
The human DENN gene: genomic organization, alternative splicing, and localization to chromosome 11p11.21-p11.22. Genome (1998) 0.90
Delta associated hepatitis in Australia. Aust N Z J Med (1983) 0.90
Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia. J Clin Microbiol (2001) 0.90
Papillomavirus and cervical cancer: a clinical and laboratory study. J Med Virol (1988) 0.90
Tympanic mucosa after tubal obstruction. Arch Otolaryngol (1970) 0.89
Experimental duck hepatitis B virus infection: pathology and evolution of hepatic and extrahepatic infection. Hepatology (1988) 0.89
Elemental composition of individual cells and tissues in the cochlea. Acta Otolaryngol (1985) 0.89
Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia. Bone Marrow Transplant (2008) 0.89
Genetic marker studies of poliovirus. II. Strains isolated from cases of poliomyelitis associated with the administration of live attenuated vaccine. J Hyg (Lond) (1967) 0.89
The current pattern of hepatitis B virus infection in Australia. J Viral Hepat (2006) 0.88
Explanation for different types of regulation of arginine biosynthesis in Escherichia coli B and Escherichia coli K12 caused by a difference between their arginine repressors. J Mol Biol (1994) 0.88
Marker studies of poliovirus. Nature (1966) 0.88
Specificity of Au antibodies. Lancet (1971) 0.88
What determines the incidence of serum hepatitis after blood transfusion? Am J Dis Child (1972) 0.88
Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transpl Surg (1998) 0.88
False-negative radioimmunoassay tests for Australia antigen. Lancet (1973) 0.88
Measuring quality of life in Chinese cancer patients: a new version of the Functional Living Index for Cancer (Chinese). Ann Acad Med Singapore (2003) 0.87
Factors associated with clinical and sub-clinical anal human papillomavirus infection in homosexual men. Genitourin Med (1991) 0.87
Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J Clin Microbiol (1997) 0.87
Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int J Cancer (2000) 0.86
Establishment of primary vestibular schwannoma cultures from neurofibromatosis type-2 patients. Int J Oncol (1999) 0.86
Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization. Surgery (2000) 0.86
Prevalence and distribution of human papillomavirus type-16 DNA in pelvic lymph nodes of patients with cervical cancer and in women with no history of cervical abnormality. Int J Cancer (1992) 0.85
Protein markers for Alzheimer disease in the frontal cortex and cerebellum. Neurology (2004) 0.84
Calcification of nontextured implantable blood pumps. Trans Am Soc Artif Intern Organs (1981) 0.84
Horizontal transmission of hepatitis B in a children's day-care centre: a preventable event. Aust N Z J Public Health (1997) 0.84
Biofilm removal by medical device cleaners: comparison of two bioreactor detection assays. J Hosp Infect (2010) 0.84
Detection of specific types of human papillomavirus in cervical scrapes, anal scrapes, and anogenital biopsies by DNA hybridization. J Med Virol (1987) 0.83
Peptides derived from the complementarity-determining regions of anti-Mac-1 antibodies block intercellular adhesion molecule-1 interaction with Mac-1. J Biol Chem (1998) 0.82
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies. Ann Oncol (2011) 0.82
Australia antigen and hepatitis in renal units. Proc Eur Dial Transplant Assoc (1972) 0.82
Evaluation of image quality using 1 : 1 pitch and 1.5 : 1 pitch helical CT in children: a comparative study. Pediatr Radiol (1996) 0.82
Identification of E6/E7 transcription patterns in HPV 16-positive cervical cancers using the reverse transcription/polymerase chain reaction. Gynecol Oncol (1995) 0.82
False-positive results with hepatitis B virus DNA dot-hybridization in hepatitis B surface antigen-negative specimens. J Clin Microbiol (1986) 0.82
Amyloid-β and Alzheimer's disease type pathology differentially affects the calcium signalling toolkit in astrocytes from different brain regions. Cell Death Dis (2013) 0.82
Molecular epidemiology and variation of hepatitis B in recent immigrant families to Australia. J Med Virol (1998) 0.81
The outcome of hepatitis B virus infection in pregnancy. Postgrad Med J (1977) 0.81
2',3'-dideoxy-3'-fluoroguanosine inhibits duck hepatitis B virus in vivo. J Viral Hepat (1996) 0.81
Reduction of murine mammary tumor metastasis by conjugated linoleic acid. Cancer Lett (2000) 0.81
Detection of HPV DNA in archival specimens of cervical cancer using in situ hybridisation and the polymerase chain reaction. J Med Virol (1992) 0.81